Literature DB >> 15982561

Host genetics and the outcome of hepatitis B viral infection.

Angela J Frodsham1.   

Abstract

Hepatitis B Virus (HBV) infection can result in numerous different clinical outcomes. A complex combination of environment, and viral and host genetic factors play a critical role in determining both susceptibility to HBV persistence and the course of infection. Evidence is presented that suggests that host genetic factors play an important role in determining the outcome of HBV infection. This data from various groups demonstrates that multiple genes play a role in determining hepatitis B viral clearance or persistence. However, to identify all the relevant variants that affect the outcome of infection, alternative strategies such as genome-wide association studies with large sample sizes will be required to define the majority of the relevant polygenes.

Entities:  

Mesh:

Year:  2005        PMID: 15982561     DOI: 10.1016/j.trim.2005.03.006

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  16 in total

1.  Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.

Authors:  Feng Lv; Yu-Feng Gao; Zhen-Huan Zhang; Tian-Chen Zhang; Fa-Ming Pan; Ming-Fang Cui; Shu-Ling Xia; Xu Li; Hua-Fa Yin
Journal:  World J Hepatol       Date:  2011-03-27

2.  Host susceptibility to persistent hepatitis B virus infection.

Authors:  Ying-Li He; Ying-Ren Zhao; Shu-Lin Zhang; Shu-Mei Lin
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

3.  Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population.

Authors:  Lifeng Liu; Jinjian Yao; Jin Li; Jinliang Zhang; Jinling Yu; Xiaorui Jiang; Shuzhen Sun; Qing Liu; Ying Chang; Yongwen He; Jusheng Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

4.  Association of GNLY genetic polymorphisms with chronic liver disease in a Korean population.

Authors:  Geun-Hee Park; Kyoung-Yeon Kim; Jae Youn Cheong; Sung Won Cho; KyuBum Kwack
Journal:  DNA Cell Biol       Date:  2012-07-12       Impact factor: 3.311

5.  Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection.

Authors:  Na Li; Yu-Feng Gao; Tian-Chen Zhang; Ping Chen; Xu Li; Fei Su
Journal:  World J Hepatol       Date:  2012-03-27

6.  Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission.

Authors:  Chih-Lin Lin; Tai-Chung Tseng; Tung-Hung Su; Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-07-21       Impact factor: 6.047

7.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.

Authors:  Yoichiro Kamatani; Sukanya Wattanapokayakit; Hidenori Ochi; Takahisa Kawaguchi; Atsushi Takahashi; Naoya Hosono; Michiaki Kubo; Tatsuhiko Tsunoda; Naoyuki Kamatani; Hiromitsu Kumada; Aekkachai Puseenam; Thanyachai Sura; Yataro Daigo; Kazuaki Chayama; Wasun Chantratita; Yusuke Nakamura; Koichi Matsuda
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

Review 8.  Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis.

Authors:  Ze-Hui Yan; Yi Fan; Xiao-Hong Wang; Qing Mao; Guo-Hong Deng; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

9.  Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection.

Authors:  Xiao-Miao Zhao; Yu-Feng Gao; Qin Zhou; Fa-Ming Pan; Xu Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers.

Authors:  Johannes Vermehren; Jörn Lötsch; Simone Susser; Sabine Wicker; Annemarie Berger; Stefan Zeuzem; Christoph Sarrazin; Alexandra Doehring
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.